Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of DiseaseMark P. Chao, Ravindra Majeti, Andreas Reinisch et al.|Cell stem cell|2017Cited by 131
Pluripotent Reprogramming of Human AML Resets Leukemic Behavior and Models Therapeutic Targeting of SubclonesMark P. Chao, Ravindra Majeti, G Vasiliev Andrew et al.|Blood|2016Cited by 0